Article
Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients.
Journal for immunotherapy of cancer - 29 Nov 2019
Wang Qinchuan, Zhang Jinhua, Tu Huakang, Liang Dong, Chang David W, Ye Yuanqing, Wu Xifeng
Abstract excerpt
BACKGROUND: Immune checkpoint inhibitors have achieved unprecedented success in cancer immunotherapy. With the exception of a few candidate biomarkers, the prognostic role of soluble immune checkpoint-related proteins in clear cell renal cell cancer (ccRCC) patients is largely uninvestigated. METHODS: We profiled the circulating levels of 14 immune checkpoint-related proteins panel (BTLA, GITR, HVEM, IDO, LAG-3,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
